| Michael Joseph Tebalt Iii, MD | |
|
298 Memorial Dr, Seneca, SC 29672-9443 | |
| (864) 885-7532 | |
| Not Available |
| Full Name | Michael Joseph Tebalt Iii |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 298 Memorial Dr, Seneca, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508968934 | NPI | - | NPPES |
| 258223 | Medicaid | SC | |
| GP2991 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25822 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Oconee Memorial Hospital | Seneca, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
With the help of two sets of brothers with autism, Johns Hopkins scientists have identified a gene associated with autism that appears to be linked very specifically to the severity of social interaction deficits.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.
Mathematicians, biostaticians and public health officials from Canada, Mexico and the United States will gather at Arizona State University this week to focus on understanding, possibly mitigating the spread of the H1N1 flu virus. They are planning to take up the challenge of proposing science-based strategies that can slow the spread of pandemic flu.
Facet Biotech Corporation (Nasdaq: FACT) and Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia (CLL).
› Verified 4 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
With the help of two sets of brothers with autism, Johns Hopkins scientists have identified a gene associated with autism that appears to be linked very specifically to the severity of social interaction deficits.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.
Mathematicians, biostaticians and public health officials from Canada, Mexico and the United States will gather at Arizona State University this week to focus on understanding, possibly mitigating the spread of the H1N1 flu virus. They are planning to take up the challenge of proposing science-based strategies that can slow the spread of pandemic flu.
Facet Biotech Corporation (Nasdaq: FACT) and Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia (CLL).
› Verified 4 days ago
| Entity Name | Anesthesiology Consultants Of The Upstate, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821002767 PECOS PAC ID: 1557265758 Enrollment ID: O20031120000288 |
News Archive
With the help of two sets of brothers with autism, Johns Hopkins scientists have identified a gene associated with autism that appears to be linked very specifically to the severity of social interaction deficits.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.
Mathematicians, biostaticians and public health officials from Canada, Mexico and the United States will gather at Arizona State University this week to focus on understanding, possibly mitigating the spread of the H1N1 flu virus. They are planning to take up the challenge of proposing science-based strategies that can slow the spread of pandemic flu.
Facet Biotech Corporation (Nasdaq: FACT) and Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia (CLL).
› Verified 4 days ago
| Entity Name | Greenville Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568532513 PECOS PAC ID: 8123938131 Enrollment ID: O20031212000723 |
News Archive
With the help of two sets of brothers with autism, Johns Hopkins scientists have identified a gene associated with autism that appears to be linked very specifically to the severity of social interaction deficits.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.
Mathematicians, biostaticians and public health officials from Canada, Mexico and the United States will gather at Arizona State University this week to focus on understanding, possibly mitigating the spread of the H1N1 flu virus. They are planning to take up the challenge of proposing science-based strategies that can slow the spread of pandemic flu.
Facet Biotech Corporation (Nasdaq: FACT) and Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia (CLL).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Joseph Tebalt Iii, MD 1 Independence Pt, Suite 212, Greenville, SC 29615-4545 Ph: (864) 797-6044 | Michael Joseph Tebalt Iii, MD 298 Memorial Dr, Seneca, SC 29672-9443 Ph: (864) 885-7532 |
News Archive
With the help of two sets of brothers with autism, Johns Hopkins scientists have identified a gene associated with autism that appears to be linked very specifically to the severity of social interaction deficits.
Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.
Mathematicians, biostaticians and public health officials from Canada, Mexico and the United States will gather at Arizona State University this week to focus on understanding, possibly mitigating the spread of the H1N1 flu virus. They are planning to take up the challenge of proposing science-based strategies that can slow the spread of pandemic flu.
Facet Biotech Corporation (Nasdaq: FACT) and Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia (CLL).
› Verified 4 days ago
Brian Bennett Chamblee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 102b Omni Dr, Seneca, SC 29672 Phone: 864-885-7971 | |
Francis Joseph Yanoviak, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 102b Omni Dr, Seneca, SC 29672 Phone: 864-885-7971 Fax: 864-885-7860 | |
Aaron Jay Bohn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 298 Memorial Dr, Seneca, SC 29672 Phone: 864-882-3351 Fax: 706-660-9390 | |
Daniel Lloyd Wright, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 298 Memorial Dr, Seneca, SC 29672 Phone: 864-882-3351 Fax: 706-660-9390 | |
Dr. H Craig Boswell, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 420 E Waterside Dr, Seneca, SC 29672 Phone: 864-882-1261 | |
Henry H Salzarulo, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10630 Clemson Blvd, 200, Seneca, SC 29678 Phone: 864-882-3351 Fax: 706-660-9390 |